Filtered By:
Vaccination: Vaccines

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 5486 results found since Jan 2013.

Retropharyngeal Abscess With Mediastinal Extension: A Case Series and Review of the Literature
We present 3 cases of retropharyngeal abscess with mediastinal extension in infants. In one case, an incompletely vaccinated 10-month-old boy presented with cough, rhinorrhea, and fever. Despite antibiotic treatment, he developed Horner's syndrome and hypoxia. A computed tomography (CT) scan showed a C1-T7 retropharyngeal abscess. He underwent transoral incision and drainage and recovered fully. In another case, a 12-month old infant presented with 8 days of fever and neck pain. A CT scan showed a retropharyngeal collection extending to the mediastinum and right hemithorax. Transoral incision and drainage and video-assiste...
Source: Ear, Nose and Throat Journal - June 13, 2023 Category: ENT & OMF Authors: Kelly A Scriven Weiner Caroline C Rieger Daniel L Wohl Earl H Harley Source Type: research

Viruses, Vol. 15, Pages 1370: Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register & ndash;12-Month Follow-Up
Viruses, Vol. 15, Pages 1370: Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up Viruses doi: 10.3390/v15061370 Authors: Mateusz Babicki Joanna Kapusta Karolina Pieniawska-Śmiech Żaneta Kałuzińska-Kołat Damian Kołat Agnieszka Mastalerz-Migas Piotr Jankowski Michał Chudzik Around the world, various vaccines have been developed to prevent the SARS-CoV-2 virus infection and consequently the COVID-19 disease. However, many patients continue to report persistent symptoms after the acute phase. Since gathering sc...
Source: Viruses - June 13, 2023 Category: Virology Authors: Mateusz Babicki Joanna Kapusta Karolina Pieniawska- Śmiech Żaneta Kałuzińska-Kołat Damian Ko łat Agnieszka Mastalerz-Migas Piotr Jankowski Micha ł Chudzik Tags: Article Source Type: research

First Vaccine For Chikungunya —An Emerging Mosquito-Borne Threat—Nears After Promising Trial Results
If approved, Valneva ’s shot could be the first approved for chikungunya, a virus transmitted by mosquitoes with similar symptoms to dengue and Zika, including severe joint pain that can last years.
Source: Forbes.com Healthcare News - June 12, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news topline Source Type: news

Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University
CONCLUSION: This study demonstrated that a heterologous second booster dose of BNT162b2 after two doses of CoronaVac induced elevated IgG against the SARS-CoV-2-spike protein and caused minor adverse reactions in healthcare workers of the Faculty of Medicine, Naresuan University. This study was registered as Thailand Clinical Trials No. TCTR20221112001.PMID:37301707 | PMC:PMC10239901 | DOI:10.1016/j.vaccine.2023.06.017
Source: Vaccine - June 10, 2023 Category: Allergy & Immunology Authors: Supawadee Makanut Apirath Wangteeraprasert Wittawat Jitpewngam Jatuporn Ngoenkam Sutatip Pongcharoen Source Type: research

COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study
In conclusion, COVID-19 vaccination was associated with a ∼1 day temporary increase in menstrual cycle length, but was not appreciably associated with other menstrual cycle characteristics.PMID:37301706 | PMC:PMC10239900 | DOI:10.1016/j.vaccine.2023.06.012
Source: Vaccine - June 10, 2023 Category: Allergy & Immunology Authors: Amelia K Wesselink Sharonda M Lovett Janice Weinberg Ruth J Geller Tanran R Wang Annette K Regan Mary D Willis Rebecca B Perkins Jennifer J Yland Martha R Koenig Kenneth J Rothman Elizabeth E Hatch Lauren A Wise Source Type: research

Locating Medical Information during an Infodemic: Information Seeking Behavior and Strategies of Health-Care Workers in Germany
CONCLUSION: Non-physician HCWs more often consulted public information sources. Employers/institutions should ensure the supply of professional, targeted COVID-19 information for different HCW groups.PMID:37297742 | DOI:10.3390/healthcare11111602
Source: Pain Physician - June 10, 2023 Category: Anesthesiology Authors: Christopher Holzmann-Littig David Stadler Maria Popp Peter Kranke Falk Fichtner Christoph Schmaderer Lutz Renders Matthias Christoph Braunisch Tarek Assali Louise Platen Marjo Wijnen-Meijer Julia L ühnen Anke Steckelberg Lisa Pfadenhauer Bernhard Haller Source Type: research

Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35  Months in South Korea
ConclusionThis active safety surveillance study confirms that QIV is well tolerated in children aged 6 –35 months in routine clinical practice in South Korea. There were no safety concerns observed in these young children.
Source: Infectious Diseases and Therapy - June 10, 2023 Category: Infectious Diseases Source Type: research

Patterns of adverse drug reactions in Jordan: a retrospective analysis of the national pharmacovigilance data registry (2015-2021)
CONCLUSIONS: This study provides contemporary insights into the post-marketing surveillance of drugs in Jordan. The findings are foundational for future studies exploring drug-ADRs causality relationships. Efforts that promote pharmacovigilance concepts should be sustained and enhanced at the national level.PMID:37293991 | DOI:10.1080/14740338.2023.2223957
Source: Expert Opinion on Drug Safety - June 9, 2023 Category: Drugs & Pharmacology Authors: Nizar M Mhaidat Osama Y Alshogran Shoroq M Altawalbeh Jaber M Jaber Hayaa A Banat Dana S Ahmad Worood Alabsi Source Type: research

Top 100 Most-Cited Papers in Herpes Zoster from 2000 to 2022: A Bibliometric Study
CONCLUSION: In terms of the quantity of T100 articles, researchers, and organizations, the US is the predominant country. The most T100 papers were published in the special journal Clinical Infectious Diseases. The most academic focus remain the remedies for postherpetic neuralgia and vaccine development for individualized groups.PMID:37273270 | PMC:PMC10237222 | DOI:10.2147/JPR.S409616
Source: Herpes - June 5, 2023 Category: Infectious Diseases Authors: Ning Gao Meng Li Weiming Wang Lei Wang Zhen Liu Yufeng Guo Source Type: research

Analyzing the effect of the COVID-19 vaccine on Parkinson ’s disease symptoms
ConclusionThere was strong evidence of worsening of PD symptoms post COVID-19 vaccination, however it was mostly mild and limited to a couple of days. The worsening had statistically significant moderate positive correlation with vaccine hesitancy and post-vaccine general side effects. A possible causative mechanism of PD symptom worsening using existing scientific knowledge would be stress and anxiety associated with vaccine hesitancy and the extent of post-vaccine general side effects (fever, chills, pain), likely via simulating a mild systemic infection/inflammation the latter already established causes of PD symptom worsening.
Source: Frontiers in Immunology - June 5, 2023 Category: Allergy & Immunology Source Type: research

Fight Aging! Newsletter, June 5th 2023
In conclusion, higher BMR might reduce lifespan. The underlying pathways linking to major causes of death and relevant interventions warrant further investigation. Betting Against Progress Turns Out Poorly, But Can Work in the Short Term in a Slow Field https://www.fightaging.org/archives/2023/06/betting-against-progress-turns-out-poorly-but-can-work-in-the-short-term-in-a-slow-field/ Setting oneself up as a spokesperson for "we will not achieve this goal", as the fellow noted here is choosing to do, is a bet against technological progress. A glance at any few decade period in the past two hundred year...
Source: Fight Aging! - June 4, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

TREMFYA ® (guselkumab) Provides Sustained Improvements Across All Minimal Disease Activity Domains for Adults Living with Active Psoriatic Arthritis in Phase 3b Trial
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment with TREMFYA® (guselkumab) provided sustainable improvements in all minimal disease activity (MDA)a domains through week 48 in adults living with active psoriatic arthritis (PsA) who previously had an inadequate response to one to two tumor necrosis factor inhibitors (TNFi-IR).[1] In a separate post-hoc analysis of the Phase 3 DISCOVER-1 and DISCOVER-2b clinical trial findings, TREMFYA was shown to be associated with prompt and su...
Source: Johnson and Johnson - May 31, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news